BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haley WE, Gilbert ON, Riley RF, Newman JC, Roumie CL, Whittle J, Kronish IM, Tamariz L, Wiggers A, Morisky DE, Conroy MB, Kovalik E, Kressin NR, Muntner P, Goff DC Jr; SPRINT Study Research Group. The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens 2016;10:857-864.e2. [PMID: 27697447 DOI: 10.1016/j.jash.2016.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ferreira JP, Gregson J, Duarte K, Gueyffier F, Rossignol P, Zannad F, Pocock S. Individualizing treatment choices in the systolic blood pressure intervention trial. J Hypertens 2018;36:428-35. [PMID: 28858981 DOI: 10.1097/HJH.0000000000001535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uchmanowicz B, Jankowska EA, Uchmanowicz I, Morisky DE. Self-Reported Medication Adherence Measured With Morisky Medication Adherence Scales and Its Determinants in Hypertensive Patients Aged ≥60 Years: A Systematic Review and Meta-Analysis. Front Pharmacol 2019;10:168. [PMID: 30930769 DOI: 10.3389/fphar.2019.00168] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
3 Vaduganathan M, Claggett BL, Juraschek SP, Solomon SD. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Cardiol 2020;5:576-81. [PMID: 32101262 DOI: 10.1001/jamacardio.2019.6192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
4 Porter IE 2nd, Palmer WC, Parker AS, Hodge DO, Diehl NN, Haley WE. Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study. J Clin Exp Hepatol 2018;8:375-9. [PMID: 30563998 DOI: 10.1016/j.jceh.2018.01.004] [Reference Citation Analysis]
5 Newman-Casey PA, Niziol LM, Mackenzie CK, Resnicow K, Lee PP, Musch DC, Heisler M. Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design. Pilot Feasibility Stud 2018;4:128. [PMID: 30062043 DOI: 10.1186/s40814-018-0320-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
6 Herman AL, Sheth KN, Williams OA, Johnston KC, Prabhakaran S, de Havenon A. Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets. J Stroke Cerebrovasc Dis 2021;31:106219. [PMID: 34826677 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106219] [Reference Citation Analysis]
7 Introna A, D'Errico E, Modugno B, Scarafino A, Fraddosio A, Distaso E, Tempesta I, Mastronardi A, Simone IL. Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study. Neuropsychiatr Dis Treat 2018;14:193-203. [PMID: 29379292 DOI: 10.2147/NDT.S150550] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Carvalho AS, Santos P. Medication Adherence In Patients With Arterial Hypertension: The Relationship With Healthcare Systems' Organizational Factors. Patient Prefer Adherence 2019;13:1761-74. [PMID: 31802854 DOI: 10.2147/PPA.S216091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
9 Walsh CA, Cahir C, Bennett KE. Association between adherence to antihypertensive medications and health outcomes in middle and older aged community dwelling adults; results from the Irish longitudinal study on ageing. Eur J Clin Pharmacol 2019;75:1283-92. [PMID: 31190134 DOI: 10.1007/s00228-019-02699-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
10 Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S, Morisky DE, Kazis LE, Ruiz-Negrón N, Powell J, Tamariz L, Whittle J, Wright JT Jr, Supiano MA, Cheung AK, Weintraub WS, Moran AE; SPRINT Research Group. Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2017;377:745-55. [PMID: 28834469 DOI: 10.1056/NEJMsa1616035] [Cited by in Crossref: 76] [Cited by in F6Publishing: 42] [Article Influence: 15.2] [Reference Citation Analysis]